Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 2
2011 7
2012 5
2013 2
2014 2
2015 3
2016 7
2017 9
2018 12
2019 9
2020 11
2021 16
2022 8
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Gauthier J, Bezerra ED, Hirayama AV, Fiorenza S, Sheih A, Chou CK, Kimble EL, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Jamieson AW, Bar M, Cassaday RD, Chapuis AG, Cowan AJ, Green DJ, Kiem HP, Milano F, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ. Gauthier J, et al. Among authors: milano f. Blood. 2021 Jan 21;137(3):323-335. doi: 10.1182/blood.2020006770. Blood. 2021. PMID: 32967009 Free PMC article. Clinical Trial.
Reply to Author.
Hill JA, Pergam SA, Boeckh M, Milano F. Hill JA, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2018 Oct;24(10):2166. doi: 10.1016/j.bbmt.2018.06.030. Epub 2018 Jun 30. Biol Blood Marrow Transplant. 2018. PMID: 29969748 Free PMC article. No abstract available.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN 3rd, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. Cowan AJ, et al. Among authors: milano f. Lancet Oncol. 2023 Jul;24(7):811-822. doi: 10.1016/S1470-2045(23)00246-2. Lancet Oncol. 2023. PMID: 37414012 Clinical Trial.
Guidelines for Cord Blood Unit Selection.
Politikos I, Davis E, Nhaissi M, Wagner JE, Brunstein CG, Cohen S, Shpall EJ, Milano F, Scaradavou A, Barker JN; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Politikos I, et al. Among authors: milano f. Biol Blood Marrow Transplant. 2020 Dec;26(12):2190-2196. doi: 10.1016/j.bbmt.2020.07.030. Epub 2020 Jul 28. Biol Blood Marrow Transplant. 2020. PMID: 32736011 Free article. Review.
Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia.
Metheny L, Politikos I, Ballen KK, Rezvani AR, Milano F, Barker JN, Brunstein CG; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Metheny L, et al. Among authors: milano f. Transplant Cell Ther. 2021 Apr;27(4):286-291. doi: 10.1016/j.jtct.2020.11.008. Transplant Cell Ther. 2021. PMID: 33836867 Free article. Review.
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.
Iovino L, Wu QV, Voutsinas J, Panaite L, Mullane E, Lynch RC, Ujjani C, Smith SD, Gopal AK, Till BG, Milano F, Chow V, Gauthier J, Turtle CJ, Maloney DG, Shadman M. Iovino L, et al. Among authors: milano f. J Cell Mol Med. 2022 Dec;26(24):5976-5983. doi: 10.1111/jcmm.17550. Epub 2022 Dec 1. J Cell Mol Med. 2022. PMID: 36453136 Free PMC article.
Towards evidence-based conservation of subterranean ecosystems.
Mammola S, Meierhofer MB, Borges PAV, Colado R, Culver DC, Deharveng L, Delić T, Di Lorenzo T, Dražina T, Ferreira RL, Fiasca B, Fišer C, Galassi DMP, Garzoli L, Gerovasileiou V, Griebler C, Halse S, Howarth FG, Isaia M, Johnson JS, Komerički A, Martínez A, Milano F, Moldovan OT, Nanni V, Nicolosi G, Niemiller ML, Pallarés S, Pavlek M, Piano E, Pipan T, Sanchez-Fernandez D, Santangeli A, Schmidt SI, Wynne JJ, Zagmajster M, Zakšek V, Cardoso P. Mammola S, et al. Among authors: milano f. Biol Rev Camb Philos Soc. 2022 Aug;97(4):1476-1510. doi: 10.1111/brv.12851. Epub 2022 Mar 21. Biol Rev Camb Philos Soc. 2022. PMID: 35315207 Free PMC article.
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.
Liang EC, Albittar A, Huang JJ, Hirayama AV, Kimble EL, Portuguese AJ, Chapuis A, Shadman M, Till BG, Cassaday RD, Milano F, Kiem HP, Riddell SR, Turtle CJ, Maloney DG, Gauthier J. Liang EC, et al. Among authors: milano f. Blood Adv. 2023 Nov 28;7(22):6990-7005. doi: 10.1182/bloodadvances.2023011399. Blood Adv. 2023. PMID: 37774014 Free PMC article. Clinical Trial.
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Le Q, Hadland B, Smith JL, Leonti A, Huang BJ, Ries R, Hylkema TA, Castro S, Tang TT, McKay CN, Perkins L, Pardo L, Sarthy J, Beckman AK, Williams R, Idemmili R, Furlan S, Ishida T, Call L, Srivastava S, Loeb AM, Milano F, Imren S, Morris SM, Pakiam F, Olson JM, Loken MR, Brodersen L, Riddell SR, Tarlock K, Bernstein ID, Loeb KR, Meshinchi S. Le Q, et al. Among authors: milano f. J Clin Invest. 2022 Nov 15;132(22):e157101. doi: 10.1172/JCI157101. J Clin Invest. 2022. PMID: 36136600 Free PMC article.
Towards the application of precision medicine in Age-Related Macular Degeneration.
Cascella R, Strafella C, Caputo V, Errichiello V, Zampatti S, Milano F, Potenza S, Mauriello S, Novelli G, Ricci F, Cusumano A, Giardina E. Cascella R, et al. Among authors: milano f. Prog Retin Eye Res. 2018 Mar;63:132-146. doi: 10.1016/j.preteyeres.2017.11.004. Epub 2017 Nov 29. Prog Retin Eye Res. 2018. PMID: 29197628 Review.
90 results